These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11248847)

  • 1. [100 years of erysipelas prophylaxis: significance and reduction of animal experiments].
    Cussler K; Balks E
    ALTEX; 2001; 18(1):29-33. PubMed ID: 11248847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
    Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
    ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
    Rosskopf-Streicher U; Johannes S; Gyra H; Beckmann R; Cussler K
    Dev Biol (Basel); 2002; 111():153-8. PubMed ID: 12678235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Swine erysipelas: from yesterday to today].
    Akkermans JP
    Tijdschr Diergeneeskd; 1987 Apr; 112(8):451-60. PubMed ID: 3554608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards in vitro potency testing of inactivated erysipelas vaccines.
    Balks E; Wolf C; Loessner H; Werner E
    Dev Biol (Basel); 2012; 134():37-44. PubMed ID: 22888593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test.
    Rosskopf-Streicher U; Johannes S; Wilhelm M; Cussler K
    Vaccine; 2001 Jan; 19(11-12):1477-83. PubMed ID: 11163671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short history of the use of animals in vaccine development and quality control.
    Hendriksen CF
    Dev Biol Stand; 1996; 86():3-10. PubMed ID: 8785959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
    Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K; Borrmann E; Werner E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antibiotics on the immune system of animals. III. Experiments in pgis immunized with live and inactivated swine erysipelas vaccines.
    Tu TD
    Acta Vet Acad Sci Hung; 1981; 28(3):317-31. PubMed ID: 7258020
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
    Beckmann R; Gyra H; Cussler K
    Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aerogenic immunization against swine erysipelas with Spirovak erysipelas vaccine "Dessau"].
    Urbaneck D; Stöhr P; Michael-Meese M
    Arch Exp Veterinarmed; 1980; 34(1):51-4. PubMed ID: 7416893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 3Rs and animal welfare - conflict or the way forward?
    Rusche B
    ALTEX; 2003; 20(Suppl 1):63-76. PubMed ID: 14671703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiments with a model of aerosol immunization of mice and swine against Erysipelothrix insidiosa (E. i.).
    Petzoldt K; Floer W; von Benten C; Stühmer A
    Dev Biol Stand; 1976; 33():57-62. PubMed ID: 955280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vaccination against swine erysipelas--field experiences in Croatia.
    Hoffmann CR; Bilkei G
    Dtsch Tierarztl Wochenschr; 2006 Jan; 113(1):13-5. PubMed ID: 16475549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies of the occurrence of erysipelas bacteria in healthy swine in the Hungarian People's Republic with reference to possible use of erysipelas live vaccines].
    Kucsera G
    Arch Exp Veterinarmed; 1980; 34(1):63-5. PubMed ID: 7416896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune reactivity of piglets vaccinated at an early age with a live vaccine against erysipelas].
    Vasilev VD; Stoev I; Khristova KhV
    Vet Med Nauki; 1978; 15(7):11-8. PubMed ID: 749325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective antigens of the swine erysipelas bacterium (Erysipelothrix rhusiopathiae. 1. Specific demonstration of the protective antigen].
    Rothe F
    Arch Exp Veterinarmed; 1982; 36(2):243-53. PubMed ID: 6808965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.